Tuberculosis, Pulmonary
Conditions
Keywords
Tuberculosis, Adherence, medication, Patient compliance
Brief summary
* Tuberculosis ( TB ) remains a major global public health problems and actions to ensure the diagnosis and complete treatment of all cases is the priority for the control of this disease. Despite the availability of effective anti-tuberculosis medications, there are still high levels of nonadherence to treatment. The nonadherence increases the morbidity and mortality of patients, decreases the cure rate, increases the community transmission and the increase of chronically ill patients enables the emergence of multi - drug resistant and increases treatment costs. * Despite the knowledge about different forms of cost-effective delivery of DOT (directly observed treatment), recognition of the need to establish the DOT strategy related to the context from local studies, in Colombia and in Cali we hadn't had made studies similar than this one that establish the cost and results of the current DOT delivery strategy and to identify other ways to improve adherence and cure rate for the TB patients at reasonable cost for both: health services and families * Therefore, this research aims to compare the cost -effectiveness of current DOT delivery method with an alternative extra- institutional delivery of anti -TB treatment in urban areas of Cali. A cost-effectiveness study was conducted from the institutional and familiar perspective with prospective information collection.
Detailed description
We compared two strategies for anti- TB treatment delivery: one institutional in which patients went to health institutions to receive treatment and other extra- institutional in which the medication was delivered in the place of choice for treating patients. Measuring the effectiveness ( compliance and cure ) was made from a controlled clinical trial , randomized , partially blinded . The measurement of family and institutional costs , direct and indirect , will be based on the activities.
Interventions
OTHERIntramural
Under this alternative, the patients will receive treatment with direct observation from health team. Treatment will be provided for free
OTHERExtramural
In this form the medication will be given by a health worker in the place chosen by patients. This option will be delivered to patients with newly diagnosed pulmonary TB without hospitalization criteria
Sponsors
Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)
Instituto Nacional de Salud Publica, Mexico
Fundación FES
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Male and female (non-pregnant) * 15 years of age and older * Living in urban area (Cali) * New diagnosed patients (TB) * In conditions to give survey information * Patients without hemoptysis and special conditions like: hepatic disease, renal failure, diabetes, hypertension, HIV/AIDS and negative test for pulmonary tuberculosis
Exclusion criteria
* Not written informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Compliance with treatment | Participants will be followed for the duration of the treatment, an expected average of six months | Total of patients who completed de treatment |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cured patients | Participants will be followed for the duration of the treatment, an expected average of six months | Total number of patients who completed the treatment and had the last or the two last smear negative and had negative cultures at the end of the treatment |
Countries
Colombia
Outcome results
None listed